BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33662364)

  • 21. Expression of MPB83 from Mycobacterium bovis in Brucella abortus S19 induces specific cellular immune response against the recombinant antigen in BALB/c mice.
    Sabio y García JV; Bigi F; Rossetti O; Campos E
    Microbes Infect; 2010 Dec; 12(14-15):1236-43. PubMed ID: 20888425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens.
    Bae JE; Schurig GG; Toth TE
    Vet Microbiol; 2002 Aug; 88(2):189-202. PubMed ID: 12135637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice.
    Jain S; Afley P; Kumar S
    World J Microbiol Biotechnol; 2013 May; 29(5):907-13. PubMed ID: 23269507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of immunization routes and protective efficacy of
    Lalsiamthara J; Won G; Lee JH
    J Vet Sci; 2018 May; 19(3):416-425. PubMed ID: 29366302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.
    Riquelme-Neira R; Retamal-Díaz A; Acuña F; Riquelme P; Rivera A; Sáez D; Oñate A
    Vaccine; 2013 Aug; 31(36):3663-7. PubMed ID: 23834811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.
    He Y; Vemulapalli R; Schurig GG
    Infect Immun; 2002 May; 70(5):2535-43. PubMed ID: 11953393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge.
    Lalsiamthara J; Lee JH
    Vet Microbiol; 2017 Jun; 205():84-91. PubMed ID: 28622869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
    Tadepalli G; Konduru B; Murali HS; Batra HV
    Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Th1/Th2-Related Immune Response against Recombinant Proteins of Brucella abortus Infection in Mice.
    Im YB; Park WB; Jung M; Kim S; Yoo HS
    J Microbiol Biotechnol; 2016 Jun; 26(6):1132-9. PubMed ID: 27012238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD.
    Jamalan M; Ardestani SK; Zeinali M; Mosaveri N; Mohammad Taheri M
    Biologicals; 2011 Jan; 39(1):23-8. PubMed ID: 20965746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Céspedes S; Cabrera A; Rivers R; González A; Muñoz C; Folch H; Andrews E
    Infect Immun; 2003 Sep; 71(9):4857-61. PubMed ID: 12933826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunization efficacy and safety of
    Wei C; Yang WH; Hou XX; Yang HY; Sun LN; Zhou DS; Li ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1103-1109. PubMed ID: 32741179
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of host infectivity, immunity, and protective efficacy by addition of sodium bicarbonate antacid to oral vaccine formulation of live attenuated Salmonella secreting Brucella antigens.
    Hewawaduge C; Senevirathne A; Lee JH
    Microb Pathog; 2020 Jan; 138():103857. PubMed ID: 31705999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.